28280631|t|Gastric metastasis of bilateral breast cancer
28280631|a|Breast cancer is the most common malignancy in women. The most frequent metastatic sites are lung, bone, liver and brain. On the other hand, gastric metastases are rare. Synchronous bilateral breast cancer (SBBC) occurs rarely. Lobular carcinoma is the histological type most often associated with bilateral breast carcinomas and gastric metastases. We made a retrospective study including four patients followed in the Salah Azaiez Institute, for a bilateral breast cancer with gastric metastases. We analyzed the epidemiological, anatomoclinical and therapeutic particularities of this rare entity. Symptoms were unspecific. The diagnosis of gastric metastasis of the SBBC was confirmed by a histopathological examination of an endoscopic biopsy. The median age was 46.2 years (range, 36-51 years) and the median time until the gastric involvement was 19 months (range, 0-41 months). None of patients had a surgical treatment for the gastric location. All Patients received at least one line of chemotherapy and radiotherapy. Median survival following the detection of gastric involvement was 22 months (range, 1-56 months). Gastric metastases from breast cancer are rare and frequently associated with other distant metastasis. Symptoms are unspecific and endoscopy may not be contributive. Therefore, gastric involvement is underestimated. Lobular infiltrating carcinoma (LIC) is the most histological type incriminated in its occurrence. The supply of immunohistochemistry is crucial to distinguish between primary or metastatic gastric cancer.
28280631	0	7	Gastric	T080	C1704242
28280631	8	18	metastasis	T191	C0027627
28280631	22	45	bilateral breast cancer	T191	C0281267
28280631	46	59	Breast cancer	T191	C0678222
28280631	72	78	common	T081	C0205214
28280631	79	89	malignancy	T191	C4282132
28280631	93	98	women	T098	C0043210
28280631	109	117	frequent	T079	C0332183
28280631	118	128	metastatic	T169	C1522484
28280631	129	134	sites	T082	C0205145
28280631	139	143	lung	T023	C0024109
28280631	145	149	bone	T023	C0262950
28280631	151	156	liver	T023	C0023884
28280631	161	166	brain	T023	C0006104
28280631	187	194	gastric	T080	C1704242
28280631	195	205	metastases	T191	C0027627
28280631	210	214	rare	T080	C0522498
28280631	216	251	Synchronous bilateral breast cancer	T191	C0281267
28280631	253	257	SBBC	T191	C0281267
28280631	266	272	rarely	T080	C0522498
28280631	274	291	Lobular carcinoma	T191	C0206692
28280631	299	316	histological type	T191	C0027652
28280631	328	343	associated with	T080	C0332281
28280631	344	371	bilateral breast carcinomas	T191	C0281267
28280631	376	383	gastric	T080	C1704242
28280631	384	394	metastases	T191	C0027627
28280631	406	425	retrospective study	T062	C0035363
28280631	426	435	including	T169	C0332257
28280631	436	440	four	T081	C0205450
28280631	441	449	patients	T101	C0030705
28280631	496	519	bilateral breast cancer	T191	C0281267
28280631	525	532	gastric	T080	C1704242
28280631	533	543	metastases	T191	C0027627
28280631	548	556	analyzed	T169	C1524024
28280631	561	576	epidemiological	T169	C0014508
28280631	578	593	anatomoclinical	T169	C0205245
28280631	598	609	therapeutic	T169	C0302350
28280631	610	625	particularities	T080	C1522508
28280631	634	638	rare	T080	C0522498
28280631	639	645	entity	T071	C1551338
28280631	647	655	Symptoms	T184	C1457887
28280631	661	671	unspecific	T080	C0205370
28280631	677	686	diagnosis	T060	C0430022
28280631	690	697	gastric	T080	C1704242
28280631	698	708	metastasis	T191	C0027627
28280631	716	720	SBBC	T191	C0281267
28280631	725	737	confirmed by	T080	C0521093
28280631	740	757	histopathological	T169	C0243140
28280631	758	769	examination	T058	C0582103
28280631	776	793	endoscopic biopsy	T060	C0184980
28280631	799	824	median age was 46.2 years	T033	C0243095
28280631	833	844	36-51 years	T079	C0439234
28280631	854	909	median time until the gastric involvement was 19 months	T033	C0243095
28280631	918	929	0-41 months	T079	C0439231
28280631	940	948	patients	T101	C0030705
28280631	955	973	surgical treatment	T061	C0543467
28280631	982	989	gastric	T080	C1704242
28280631	990	998	location	T029	C0005898
28280631	1004	1012	Patients	T101	C0030705
28280631	1013	1021	received	T080	C1514756
28280631	1043	1055	chemotherapy	T061	C3665472
28280631	1060	1072	radiotherapy	T061	C1522449
28280631	1074	1089	Median survival	T079	C2986586
28280631	1090	1099	following	T079	C0332282
28280631	1104	1113	detection	T061	C1511790
28280631	1117	1136	gastric involvement	T029	C0005898
28280631	1141	1150	22 months	T079	C0439231
28280631	1159	1170	1-56 months	T079	C0439231
28280631	1173	1180	Gastric	T080	C1704242
28280631	1181	1191	metastases	T191	C0027627
28280631	1197	1210	breast cancer	T191	C0678222
28280631	1215	1219	rare	T080	C0522498
28280631	1235	1250	associated with	T080	C0332281
28280631	1257	1264	distant	T082	C0443203
28280631	1265	1275	metastasis	T191	C0027627
28280631	1277	1285	Symptoms	T184	C1457887
28280631	1290	1300	unspecific	T080	C0205370
28280631	1305	1314	endoscopy	T060	C0014245
28280631	1319	1322	not	T169	C1518422
28280631	1326	1338	contributive	T052	C1880177
28280631	1351	1358	gastric	T080	C1704242
28280631	1359	1370	involvement	T169	C1314939
28280631	1390	1420	Lobular infiltrating carcinoma	T191	C0206692
28280631	1422	1425	LIC	T191	C0206692
28280631	1439	1456	histological type	T191	C0027652
28280631	1477	1487	occurrence	T079	C2745955
28280631	1503	1523	immunohistochemistry	T060	C0021044
28280631	1558	1565	primary	T080	C0205225
28280631	1569	1579	metastatic	T169	C1522484
28280631	1580	1594	gastric cancer	T191	C0699791